Home / News / India News / Article / Biocon gets Rs 460 cr insulin order from Malaysia

Biocon gets Rs 460 cr insulin order from Malaysia

Biotech major Biocon on Thursday said its Malaysian subsidiary has won a Rs 460 crore order to supply recombinant human insulin to the Malaysian health ministry

  • WhatsAppBookmarkBookmark
Listen to this article :

Bengaluru: Biotech major Biocon on Thursday said its Malaysian subsidiary has won a Rs 460 crore order to supply recombinant human insulin to the Malaysian health ministry.

"The insulin cartridges and re-usable pens will be produced and supplied from our biopharmaceutical plant at Johor in Malyasia under its government's off-take agreement initiative, which promotes local manufacturing and lowers reliance on imported medicines," the city-based pharma said in a statement here.

Read Next Story
Two children killed as lighting strikes parts of Rajasthan›

Trending Stories

Latest Photoscta-pos

Latest VideosView All

Latest Web StoriesView All

Mid-Day FastView All